Hengyuan Li

Zhejiang University

38 Zheda Road

Hangzhou, 310058

China

SCHOLARLY PAPERS

1

DOWNLOADS

14

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Anti-PD-1 Antibody Plus Anlotinib Versus Anlotinib Alone in Patients with Refractory Dedifferentiated or High-Grade Conventional Chondrosarcoma (FLAIL-C): A Multicenter, Controlled, Nonrandomized, Phase 2 Trial

Number of pages: 31 Posted: 18 Sep 2024
Zhejiang University - Department of Orthopaedics, Peking University, Wenzhou Medical University, Zhejiang University, Hangzhou Third People’s Hospital, Zhejiang University, Zhejiang University, Tianjin Medical University, Nanjing University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Tianjin Medical University - Tianjin Medical University Cancer Institute and Hospital, Nanjing University, Zhejiang University - Department of Orthopaedic Surgery, Independent and Independent
Downloads 14 (1,232,144)
Citation 1

Abstract:

Loading...

chondrosarcoma, immunotherapy, biomarker, tyrosine kinase inhibitor